The Ayurveda Experience is a personal care and wellness brand that provides personal care products, food and beverages, supplements, and other products aimed at modern health and beauty needs. Its product mix spans personal care, food & beverage, and dietary supplements. The company recently secured $26.6 million in a Series C financing. The round was backed by Jungle Ventures, Anicut Capital, SIDBI Venture Capital, and Sharrp Ventures. The article does not disclose additional operating metrics such as revenue or user numbers. No future plans or use of proceeds were detailed in the article. The Ayurveda Experience is a D2C skincare and nutrition brand that packages Ayurvedic consultation, content, webinars, products and courses into modern self-care solutions. The company says it translates ancient Ayurvedic science into convenient, aspirational daily offerings for global consumers. It plans to use new funding to enter new geographies, expand in existing markets, and strengthen R&D, supply chain and manufacturing capabilities. Management also intends to invest in technologies to personalize the customer experience on its platform; the brand opened its first offline store in Torrance, Los Angeles in October. Founded by Rishabh Chopra in 2010 and based in Gurugram, the company targets rapid growth (a stated vision of 46% CAGR over five years). Financially it reported more than Rs 235 crore in revenue last year, an annualized run rate of over Rs 280 crore, and a customer base of about 840,000. The Ayurveda Experience (TAE) is a Delhi-based company that manufactures, sells and distributes Ayurvedic products in India and globally through its brands iYURA and Ajara. The company plans to scale up its research and development facility to strengthen its product portfolio and increase its geographic reach. TAE received a Rs 10 crore investment from Kalpavriksh, the private equity fund of Centrum Group. As part of the agreement, Giri Krishnaswamy, CIO of Kalpavriksh, will join the company's board. The infusion is intended to support R&D expansion and market growth. Kalpavriksh's broader portfolio includes investments in The HEAL Institute, The Label Life and Littlemore Innovation Labs.

Total raised

$34M

Funding rounds

3

Latest round

Series C

Latest activity

Mar 2024